IGFBP-6 and Its Role in Breast Cancer
Author Information
Author(s): Lariz Francisco J., Botero Pacha B., Shoffstall Isabella, Houston Kevin D.
Primary Institution: New Mexico State University, Department of Chemistry and Biochemistry, Las Cruces, NM, United States
Hypothesis
Does IGFBP-6 modulate the effects of progesterone in breast cancer?
Conclusion
High levels of IGFBP-6 are associated with improved survival in progesterone receptor positive breast cancer patients.
Supporting Evidence
- High IGFBP-6 expression is associated with better overall survival in PR positive breast cancer patients.
- Knockdown of IGFBP-6 counteracts the protective effects of progesterone.
- Stable overexpression of IGFBP-6 increases EGFR levels in response to hormonal treatments.
Takeaway
This study found that a protein called IGFBP-6 helps protect breast cancer cells from growing too much when treated with progesterone.
Methodology
Survival analysis using Kaplan-Meier plots and cell culture experiments with T47D breast cancer cells.
Limitations
The study primarily used cell lines and did not include in vivo experiments.
Participant Demographics
The study focused on hormone receptor positive breast cancer patients.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website